Familial Cervical Cancer: Case Reports, Review and Clinical Implications

od Zoodsma Margreet, Sijmons Rolf H, de Vries Elisabeth GE, Zee Ate
Wydane 2004-05-01

Familial Cervical Cancer: Case Reports, Review and Clinical Implications

od Zoodsma, Margreet, Sijmons, Rolf H, de Vries, Elisabeth GE, Zee, Ate GJ van der
Wydane 2004

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5

od van Geelen, Caroline MM, Pennarun, Bodvael, Le, Phuong TK, de Vries, Elisabeth GE, de Jong, Steven
Wydane 2011

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

od Nienhuis, Hilde H., Arjaans, Marlous, Timmer-Bosscha, Hetty, de Vries, Elisabeth G.E., Schröder, Carolina P.
Wydane w Oncotarget (2015)

ATP-binding cassette (ABC) transporters in normal and pathological lung

od van der Deen, Margaretha, de Vries, Elisabeth GE, Timens, Wim, Scheper, Rik J, Timmer-Bosscha, Hetty, Postma, Dirkje S
Wydane 2005

Inhibition of IGF-1R-Dependent PI3K Activation Sensitizes Colon Cancer Cells Specifically to DR5-Mediated Apoptosis But Not to rhTRAIL

od Pennarun, Bodvael, Kleibeuker, Jan H., Oenema, Tjitske, Stegehuis, Janet H., de Vries, Elisabeth G.E., de Jong, Steven
Wydane w Anal Cell Pathol (Amst) (2010)

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

od Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E.
Wydane w Oncotarget (2016)

APC/C(C)(dh1) controls CtIP stability during the cell cycle and in response to DNA damage

od Lafranchi, Lorenzo, de Boer, Harmen R, de Vries, Elisabeth GE, Ong, Shao-En, Sartori, Alessandro A, van Vugt, Marcel ATM
Wydane w EMBO J (2014)

Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types

od Lamberts, Laetitia E., de Groot, Derk Jan A., Bense, Rico D., de Vries, Elisabeth G.E., Fehrmann, Rudolf S.N.
Wydane w Oncotarget (2015)

Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine

od Pool, Martin, de Boer, H. Rudolf, Hooge, Marjolijn N. Lub-de, van Vugt, Marcel A.T.M., de Vries, Elisabeth G.E.
Wydane w Theranostics (2017)

Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours

od Koornstra, Jan J., de Jong, Steven, Boersma-van Eck, Wietske, Zwart, Nynke, Hollema, Harry, de Vries, Elisabeth G.E., Kleibeuker, Jan H.
Wydane 2008

MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells

od Stutvoet, Thijs S, Kol, Arjan, de Vries, Elisabeth GE, de Bruyn, Marco, Fehrmann, Rudolf SN, Terwisscha van Scheltinga, Anton GT, de Jong, Steven
Wydane w J Pathol (2019)

Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

od Waaijer, Stijn JH, Giesen, Danique, Ishiguro, Takahiro, Sano, Yuji, Sugaya, Naofumi, Schröder, Carolina P, de Vries, Elisabeth GE, Lub-de Hooge, Marjolijn N
Wydane w J Immunother Cancer (2020)

Pancreatic cyst development: insights from von Hippel-Lindau disease

od van Asselt, Sophie J, de Vries, Elisabeth GE, van Dullemen, Hendrik M, Brouwers, Adrienne H, Walenkamp, Annemiek ME, Giles, Rachel H, Links, Thera P
Wydane 2013

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer (89)Zr-imgatuzumab

od Pool, Martin, Kol, Arjan, Lub-de Hooge, Marjolijn N., Gerdes, Christian A., de Jong, Steven, de Vries, Elisabeth G.E., Terwisscha van Scheltinga, Anton G.T.
Wydane w Oncotarget (2016)

Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent

od di Pietro, Alessandra, Koster, Roelof, Boersma-van Eck, Wytske, Dam, Wendy A., Mulder, Nanno H., Gietema, Jourik A., de Vries, Elisabeth G.E., de Jong, Steven
Wydane 2012

Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity

od Heijink, Anne Margriet, Everts, Marieke, Honeywell, Megan E., Richards, Ryan, Kok, Yannick P., de Vries, Elisabeth G.E., Lee, Michael J., van Vugt, Marcel A.T.M.
Wydane w Cell Rep (2019)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

od Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
Wydane w Gastrointest Cancer Res (2014)

ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody (89)Zr-RG7116

od Terwisscha van Scheltinga, Anton GT, Lub-de Hooge, Marjolijn N, Abiraj, Keelara, Schröder, Carolien P, Pot, Linda, Bossenmaier, Birgit, Thomas, Marlene, Hölzlwimmer, Gabriele, Friess, Thomas, Kosterink, Jos GW, de Vries, Elisabeth GE
Wydane 2014

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study

od Sanborn, Rachel E, Hamid, Omid, de Vries, Elisabeth GE, Ott, Patrick A, Garcia-Corbacho, Javier, Boni, Valentina, Bendell, Johanna, Autio, Karen A, Cho, Daniel C, Plummer, Ruth, Stroh, Mark, Lu, Lawrence, Thistlethwaite, Fiona
Wydane w J Immunother Cancer (2021)